Works matching IS 14642662 AND DT 2011 AND VI 12

Results: 127

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.

Published in:

2011

By:

Vrouenraets, Sme;
Wit, Fwnm;
Fernandez Garcia, E;
Moyle, Gj;
Jackson, Ag;
Allavena, C;
Raffi, F;
Jayaweera, Dt;
Mauss, S;
Katlama, C;
Fisher, M;
Slama, L;
Hardy, Wd;
DeJesus, E;
van Eeden, A;
Reiss, P

Publication type:

Journal Article

Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)

Published in:

2011

By:

Feeney, Er;
Chazallon, C;
O'Brien, N;
Meiffrédy, V;
Goodall, Rl;
Aboulker, J-P;
Cooper, Da;
Yeni, P;
Mallon, Pwg

Publication type:

Journal Article

Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?

Published in:

HIV Medicine, 2011, v. 12, n. 10, p. 610, doi. 10.1111/j.1468-1293.2011.00938.x

By:

McManus, H;
Li, PCK;
Nolan, D;
Bloch, M;
Kiertiburanakul, S;
Choi, JY;
Mulhall, B;
Petoumenos, K;
Zhou, J;
Law, M;
Brew, BJ;
Wright, E

Publication type:

Article

A note of thanks to referees for Volume 12, 2011.

Published in:: 2011
Publication type:: Other

Acute systemic inflammation induced by influenza A (H1N1) vaccination causes a deterioration in endothelial function in HIV-infected patients.

Published in:

HIV Medicine, 2011, v. 12, n. 10, p. 594, doi. 10.1111/j.1468-1293.2011.00935.x

By:

Vlachopoulos, C;
Xaplanteris, P;
Sambatakou, H;
Mariolis, E;
Bratsas, A;
Christoforatou, E;
Miliou, A;
Aznaouridis, K;
Stefanadis, C

Publication type:

Article

First trimester maternal uterine artery Doppler examination in HIV-positive women.

Published in:

HIV Medicine, 2011, v. 12, n. 10, p. 632, doi. 10.1111/j.1468-1293.2011.00930.x

By:

Savvidou, MD;
Samuel, MI;
Akolekar, R;
Poulton, M;
Nicolaides, KH

Publication type:

Article

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.

Published in:

HIV Medicine, 2011, v. 12, n. 10, p. 620, doi. 10.1111/j.1468-1293.2011.00941.x

By:

Vrouenraets, SME;
Wit, FWNM;
Fernandez Garcia, E;
Moyle, GJ;
Jackson, AG;
Allavena, C;
Raffi, F;
Jayaweera, DT;
Mauss, S;
Katlama, C;
Fisher, M;
Slama, L;
Hardy, WD;
DeJesus, E;
van Eeden, A;
Reiss, P

Publication type:

Article

Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).

Published in:

HIV Medicine, 2011, v. 12, n. 10, p. 602, doi. 10.1111/j.1468-1293.2011.00934.x

By:

Feeney, ER;
Chazallon, C;
O'Brien, N;
Meiffrédy, V;
Goodall, RL;
Aboulker, J-P;
Cooper, DA;
Yeni, P;
Mallon, PWG

Publication type:

Article

Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.

Published in:

HIV Medicine, 2011, v. 12, n. 10, p. 583, doi. 10.1111/j.1468-1293.2011.00929.x

By:

Hughes, RA;
Sterne, JAC;
Walsh, J;
Bansi, L;
Gilson, R;
Orkin, C;
Hill, T;
Ainsworth, J;
Anderson, J;
Gompels, M;
Dunn, D;
Johnson, MA;
Phillips, AN;
Pillay, D;
Leen, C;
Easterbrook, P;
Gazzard, B;
Fisher, M;
Sabin, CA

Publication type:

Article

Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 553, doi. 10.1111/j.1468-1293.2011.00923.x

By:

Iwuji, CC;
Mayanja, BN;
Weiss, HA;
Atuhumuza, E;
Hughes, P;
Maher, D;
Grosskurth, H

Publication type:

Article

Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 570, doi. 10.1111/j.1468-1293.2011.00927.x

By:

Conradie, F;
Zorrilla, C;
Josipovic, D;
Botes, M;
Osiyemi, O;
Vandeloise, E;
Eley, T;
Child, M;
Bertz, R;
Hu, W;
Wirtz, V;
McGrath, D

Publication type:

Article

Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 544, doi. 10.1111/j.1468-1293.2011.00922.x

By:

Verhofstede, C;
Brudney, D;
Reynaerts, J;
Vaira, D;
Fransen, K;
De Bel, A;
Seguin-Devaux, C;
De Wit, S;
Vandekerckhove, L;
Geretti, A-M

Publication type:

Article

Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 535, doi. 10.1111/j.1468-1293.2011.00919.x

By:

Yehia, BR;
Fleishman, JA;
Wilson, L;
Hicks, PL;
Gborkorquellie, TT;
Gebo, KA

Publication type:

Article

Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 525, doi. 10.1111/j.1468-1293.2011.00921.x

By:

Kenya, S;
Chida, N;
Symes, S;
Shor-Posner, G

Publication type:

Article

British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 517, doi. 10.1111/j.1468-1293.2011.00954.x

By:

Pozniak, AL;
Coyne, KM;
Miller, RF;
Lipman, MCI;
Freedman, AR;
Ormerod, LP;
Johnson, MA;
Collins, S

Publication type:

Article

HIV antiretroviral therapy reduces circulating surfactant protein-D levels.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 580, doi. 10.1111/j.1468-1293.2011.00920.x

By:

Kunisaki, KM;
Quick, H;
Baker, JV

Publication type:

Article

Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.

Published in:

HIV Medicine, 2011, v. 12, n. 9, p. 562, doi. 10.1111/j.1468-1293.2011.00928.x

By:

Grierson, J;
Koelmeyer, RL;
Smith, A;
Pitts, M

Publication type:

Article

4 Gastrointestinal opportunistic infections.

Published in:

2011

By:

Beeching, N. J.;
Jones, R.;
Gazzard, B.

Publication type:

Journal Article

8 Mycobacterium avium complex and Mycobacterium kansasii.

Published in:

2011

By:

Fisher, M.;
Ong, E.;
Pozniak, A.

Publication type:

Journal Article

5 Ocular infections.

Published in:

2011

By:

Mitchell, S. M.;
Shiew, M. M. F.;
Nelson, M.

Publication type:

Journal Article

1 Introduction.

Published in:

2011

By:

Edwards, S.;
Dockrell, D. H.;
Nelson, M.

Publication type:

Journal Article

10 Travel-related opportunistic infections.

Published in:

2011

By:

Angus, B. J.;
Schmid, M. L.;
Dockrell, D. H.;
Grant, A. D.

Publication type:

Journal Article

6 Herpes viruses.

Published in:

2011

By:

Williams, I.;
Leen, C.;
Barton, S.

Publication type:

Journal Article

2 Central nervous system opportunistic infections.

Published in:

2011

By:

Nelson, M.;
Manji, H.;
Wilkins, E.

Publication type:

Journal Article

11 Special considerations in pregnancy.

Published in:

2011

By:

Greig, J. M.;
Wood, C. G. A.;
Clarke, S. U.

Publication type:

Journal Article

7 Candidiasis.

Published in:

2011

By:

Cartledge, J.;
Freedman, A.

Publication type:

Journal Article

3 Pulmonary opportunistic infections.

Published in:

2011

By:

Dockrell, D. H.;
Breen, R.;
Lipman, M.;
Miller, R. F.

Publication type:

Journal Article

12 Intensive care.

Published in:

2011

By:

Miller, R.;
Edwards, S.;
Singer, M.

Publication type:

Journal Article

9 Pyrexia of unknown origin (PUO).

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 83, doi. 10.1111/j.1468-1293.2011.00944_10.x

By:

Edwards, S.;
Bergin, C.;
Miller, R.

Publication type:

Article

British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 1, doi. 10.1111/j.1468-1293.2011.00944_1.x

By:

Nelson, M;
Dockrell, DH;
Edwards, S

Publication type:

Article

13 A-Z of drugs used in the treatment of opportunist infections in HIV (Appendix 1).

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 112, doi. 10.1111/j.1468-1293.2011.00944_14.x

By:

Weston, R.;
Khoo, S.

Publication type:

Article

4 Gastrointestinal opportunistic infections.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 43, doi. 10.1111/j.1468-1293.2011.00944_5.x

By:

Beeching, N. J.;
Jones, R.;
Gazzard, B.

Publication type:

Article

8 Mycobacterium avium complex and Mycobacterium kansasii.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 75, doi. 10.1111/j.1468-1293.2011.00944_9.x

By:

Fisher, M.;
Ong, E.;
Pozniak, A.

Publication type:

Article

12 Intensive care.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 109, doi. 10.1111/j.1468-1293.2011.00944_13.x

By:

Miller, R.;
Edwards, S.;
Singer, M.

Publication type:

Article

10 Travel-related opportunistic infections.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 88, doi. 10.1111/j.1468-1293.2011.00944_11.x

By:

Angus, B. J.;
Schmid, M. L.;
Dockrell, D. H.;
Grant, A. D.

Publication type:

Article

7 Candidiasis.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 70, doi. 10.1111/j.1468-1293.2011.00944_8.x

By:

Cartledge, J.;
Freedman, A.

Publication type:

Article

11 Special considerations in pregnancy.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 102, doi. 10.1111/j.1468-1293.2011.00944_12.x

By:

Greig, J. M.;
Wood, C. G. A.;
Clarke, S. U.

Publication type:

Article

2 Central nervous system opportunistic infections.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 8, doi. 10.1111/j.1468-1293.2011.00944_3.x

By:

Nelson, M.;
Manji, H.;
Wilkins, E.

Publication type:

Article

6 Herpes viruses.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 61, doi. 10.1111/j.1468-1293.2011.00944_7.x

By:

Williams, I.;
Leen, C.;
Barton, S.

Publication type:

Article

3 Pulmonary opportunistic infections.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 25, doi. 10.1111/j.1468-1293.2011.00944_4.x

By:

Dockrell, D. H.;
Breen, R.;
Lipman, M.;
Miller, R. F.

Publication type:

Article

1 Introduction.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 6, doi. 10.1111/j.1468-1293.2011.00944_2.x

By:

Edwards, S.;
Dockrell, D. H.;
Nelson, M.

Publication type:

Article

Appendix 2.

Published in:: HIV Medicine, 2011, v. 12, n. S2, p. 140, doi. 10.1111/j.1468-1293.2011.00944_15.x
Publication type:: Article

5 Ocular infections.

Published in:

HIV Medicine, 2011, v. 12, n. S2, p. 55, doi. 10.1111/j.1468-1293.2011.00944_6.x

By:

Mitchell, S. M.;
Shiew, M. M. F.;
Nelson, M.

Publication type:

Article

Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.

Published in:

HIV Medicine, 2011, v. 12, n. 8, p. 506, doi. 10.1111/j.1468-1293.2011.00913.x

By:

Trimoulet, P.;
Belzunce, C.;
Faure, M.;
Wittkop, L.;
Reigadas, S.;
Dupon, M.;
Ragnaud, J.-M.;
Fleury, H.;
Neau, D.

Publication type:

Article

Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.

Published in:

HIV Medicine, 2011, v. 12, n. 8, p. 453, doi. 10.1111/j.1468-1293.2010.00906.x

By:

Sivakumar, T.;
Mechanic, O. J.;
Fehmie, D. A.;
Paul, B. T.

Publication type:

Article

Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.

Published in:

HIV Medicine, 2011, v. 12, n. 8, p. 487, doi. 10.1111/j.1468-1293.2011.00912.x

By:

Neukam, K.;
Nattermann, J.;
Rallón, N.;
Rivero, A.;
Caruz, A.;
Macías, J.;
Vogel, M.;
Benito, J. M.;
Camacho, Á;
Mira, J. A.;
Schwarze-Zander, C.;
Barreiro, P.;
Martínez, A.;
Rockstroh, J. K.;
Soriano, V.;
Pineda, J. A.

Publication type:

Article

Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais.

Published in:

HIV Medicine, 2011, v. 12, n. 8, p. 510, doi. 10.1111/j.1468-1293.2011.00916.x

By:

Edwards-Jackson, N.;
Kerr, S. J.;
Tieu, H. V.;
Ananworanich, J.;
Hammer, S. M.;
Ruxrungtham, K.;
Phanuphak, P.;
Avihingsanon, A.

Publication type:

Article

Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.

Published in:

HIV Medicine, 2011, v. 12, n. 8, p. 481, doi. 10.1111/j.1468-1293.2010.00911.x

By:

Gonzalez, G.;
Park, S. S.;
Chen, D. W.;
Armitage, S.;
Shpall, E. J.;
Behringer, R. R.

Publication type:

Article

Decision-making by people living with HIV requires communication from clinicians about the risks of transmission despite undetectable plasma viral load.

Published in:

HIV Medicine, 2011, v. 12, n. 8, p. 516, doi. 10.1111/j.1468-1293.2010.00909.x

By:

Hosein, S. R.;
Wilson, D. P.

Publication type:

Article

Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons.

Published in:

HIV Medicine, 2011, v. 12, n. 8, p. 463, doi. 10.1111/j.1468-1293.2010.00904.x

By:

Crum-Cianflone, N. F.;
Krause, D.;
Wessman, D.;
Medina, S.;
Stepenosky, J.;
Brandt, C.;
Boswell, G.

Publication type:

Article